1315 Capital and John Martin Invest in Innovative ECMO Concepts
October 4, 2022
Innovative ECMO Concepts received a growth capital investment from 1315 Capital and John Martin, who was also named CEO. The funding will support expansion of the company's ECMO staffing, on-demand training, and patient transport services to increase ECMO capacity at hospitals and broaden access to ECLS.
- Buyers
- 1315 Capital, John Martin
- Targets
- Innovative ECMO Concepts
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Integration Health Acquires ECMO Advantage
September 18, 2025
Healthcare Services
Integration Health has acquired ECMO Advantage, combining two leading ECMO, perfusion, and transplant support providers to create a unified national platform. The combined organization will serve over 55 hospitals across 22 states, expanding specialized clinical staffing, program development, transport, and education services for ECMO and perfusion care.
-
1315 Capital Leads Growth Investment in Experic
October 29, 2024
Pharmaceuticals
Experic, a Cranbury, New Jersey-based CDMO and clinical trial supply services firm, received a growth capital investment led by 1315 Capital with participation from existing investors East Seattle Partners, Harro Höfliger Packaging Systems, Inc., and Kineticos Ventures. The capital will be used to enhance Experic’s manufacturing capabilities and accelerate its international expansion to better serve biopharmaceutical clients.
-
1315 Capital Acquires Biocoat, Inc.
January 16, 2019
Medical Devices
Philadelphia-based healthcare investment firm 1315 Capital has acquired Biocoat, Inc., a Horsham, Pennsylvania specialty manufacturer of hydrophilic biomaterial coatings for medical devices; the transaction closed on December 20, 2018. 1315 Capital's investment will provide expansion and growth capital to accelerate R&D, expand Biocoat's operating model, and support broader commercial efforts across neurovascular, cardiovascular, peripheral, and ophthalmic end markets.
-
Enhanced Healthcare Partners Makes Growth Investment in Janus Health
March 21, 2023
Healthcare Services
Enhanced Healthcare Partners (EHP) announced a strategic growth investment in Janus, a provider of AI-enabled revenue cycle management (RCM) technology. The capital will support Janus' market expansion, product development and go-to-market initiatives to accelerate adoption across health systems and RCM service providers.
-
1315 Capital Invests in Triple Ring Technologies
February 1, 2024
Healthcare Services
1315 Capital, a Philadelphia-based healthcare growth equity firm, made a growth capital investment in Triple Ring Technologies, a Silicon Valley-based medical device and life sciences co-development and engineering services company. The investment will accelerate Triple Ring's geographic expansion and extension of its R&D and product development services to scale its engineering and outsourced R&D services platform.
-
Intrepid Makes Strategic Investment in ECOTEC International Holdings
February 3, 2022
Energy
Funds managed by Intrepid Investment Management (the investing arm of Intrepid Financial Partners) have made a strategic growth investment in ECOTEC International Holdings, LLC to accelerate production and the roll-out of its methane emissions instrumentation and emissions data software. The capital and Intrepid's energy-sector expertise will support ECOTEC's expansion into oil and gas while meeting strong demand in the biogas and natural gas markets.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.